Last 12 months
Inside the activity.
22 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 6 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 10 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 6 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2021 Filed May 18, 2021 20:47 UTC |
FARRELL STEPHEN CDirector
|
Disposition to issuerCommon Stock | 5,328 | $113.87 | $606,699.36 |
DisclosureSEC source: 0001209191-21-033541 · doc4.xml · nonDerivative · entry 2 FARRELL STEPHEN C · CIK 0001188757 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,808 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.86 to $117.81, inclusive. Read SEC document |
| May 17, 2021 Filed May 18, 2021 20:47 UTC |
FARRELL STEPHEN CDirector
|
Exercise / conversionCommon Stock | 5,328 | $7.14 | $38,041.92 |
DisclosureSEC source: 0001209191-21-033541 · doc4.xml · nonDerivative · entry 1 FARRELL STEPHEN C · CIK 0001188757 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 348 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · derivative · entry 12 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 348 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2021. Read SEC document |
| May 12, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 231 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · derivative · entry 11 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,041 Underlying: Common Stock · 231 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022. Read SEC document |
| May 12, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 375 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · derivative · entry 10 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2021. Read SEC document |
| May 12, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock | 348 | $16.15 | $5,620.20 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · nonDerivative · entry 7 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock | 231 | $35.98 | $8,311.38 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · nonDerivative · entry 6 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock | 375 | $29.80 | $11,175.00 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · nonDerivative · entry 5 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
SaleCommon Stock | 5,531 | $110.74 | $612,502.94 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · nonDerivative · entry 4 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,847 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $112.29, inclusive. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:11 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 53,500 | $0.00 Strike: $7.76 | $0.00 |
DisclosureSEC source: 0001209191-21-032113 · doc4.xml · derivative · entry 6 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,000 Underlying: Common Stock · 53,500 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:11 UTC |
Mason Caren LDirector · President & CEO
|
SaleCommon Stock | 53,500 | $110.70 | $5,922,450.00 |
DisclosureSEC source: 0001209191-21-032113 · doc4.xml · nonDerivative · entry 4 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,376 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.29 to $113.55. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:11 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 53,500 | $7.76 | $415,160.00 |
DisclosureSEC source: 0001209191-21-032113 · doc4.xml · nonDerivative · entry 3 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 10,025 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · derivative · entry 9 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,737 Underlying: Common Stock · 10,025 shares Expires 2030-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 1,050 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · derivative · entry 8 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,272 Underlying: Common Stock · 1,050 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
SaleCommon Stock | 11,075 | $111.61 | $1,236,080.75 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · nonDerivative · entry 3 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,378 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.08 to $113.18, inclusive. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock | 10,025 | $27.53 | $275,988.25 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · nonDerivative · entry 2 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:03 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock | 1,050 | $35.98 | $37,779.00 |
DisclosureSEC source: 0001209191-21-032100 · doc4.xml · nonDerivative · entry 1 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:11 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 53,500 | $0.00 Strike: $7.76 | $0.00 |
DisclosureSEC source: 0001209191-21-032113 · doc4.xml · derivative · entry 5 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,500 Underlying: Common Stock · 53,500 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:11 UTC |
Mason Caren LDirector · President & CEO
|
SaleCommon Stock | 53,500 | $119.88 | $6,413,580.00 |
DisclosureSEC source: 0001209191-21-032113 · doc4.xml · nonDerivative · entry 2 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,376 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.27 to $135.64. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:11 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 53,500 | $7.76 | $415,160.00 |
DisclosureSEC source: 0001209191-21-032113 · doc4.xml · nonDerivative · entry 1 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:06 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 8,874 | $125.83 | $1,116,615.42 |
DisclosureSEC source: 0001209191-21-032102 · doc4.xml · nonDerivative · entry 1 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,721 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.85 to $135.64, inclusive. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 5,523 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · derivative · entry 10 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,774 Underlying: Common Stock · 5,523 shares Expires 2030-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 3,462 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · derivative · entry 9 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,564 Underlying: Common Stock · 3,462 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 2,534 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · derivative · entry 8 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 2,534 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2028. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 7,200 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · derivative · entry 7 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,200 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2028. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
SaleCommon Stock | 10,760 | $124.13 | $1,335,638.80 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 6 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,301 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.85 to $135.64, inclusive. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 5,523 | $27.53 | $152,048.19 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 5 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 3,462 | $35.98 | $124,562.76 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 4 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 2,534 | $29.80 | $75,513.20 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 7,200 | $16.15 | $116,280.00 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
SaleCommon Stock | 1,349 | $125.22 | $168,921.78 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,342 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.02 to $135.64, inclusive. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:01 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock Options · Derivative | 9,425 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001209191-21-032097 · doc4.xml · derivative · entry 5 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,075 Underlying: Common Stock · 9,425 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:01 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock Options · Derivative | 2,158 | $0.00 Strike: $7.35 | $0.00 |
DisclosureSEC source: 0001209191-21-032097 · doc4.xml · derivative · entry 4 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,158 shares Expires 2025-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:01 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
SaleCommon Stock | 11,583 | $125.72 | $1,456,214.76 |
DisclosureSEC source: 0001209191-21-032097 · doc4.xml · nonDerivative · entry 3 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,630 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.25 to $130.64, inclusive. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:01 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock | 9,425 | $7.52 | $70,876.00 |
DisclosureSEC source: 0001209191-21-032097 · doc4.xml · nonDerivative · entry 2 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:01 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock | 2,158 | $7.35 | $15,861.30 |
DisclosureSEC source: 0001209191-21-032097 · doc4.xml · nonDerivative · entry 1 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:50 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
SaleCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-21-003110 · ownership.xml · nonDerivative · entry 6 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,326,185 F1 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 22:50 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
SaleCommon Stock | 43,383 | $135.30 | $5,869,719.90 |
DisclosureSEC source: 0000919574-21-003110 · ownership.xml · nonDerivative · entry 5 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,326,185 F4 · price: This constitutes the weighted average sale price. The prices range from $134.00 to $136.10. The Reporting Persons will provide upon request by the SEC Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 23, 2021 Filed Apr 26, 2021 22:50 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
SaleCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-21-003110 · ownership.xml · nonDerivative · entry 4 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,369,568 F1 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 23, 2021 Filed Apr 26, 2021 22:50 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
SaleCommon Stock | 53,854 | $133.51 | $7,190,047.54 |
DisclosureSEC source: 0000919574-21-003110 · ownership.xml · nonDerivative · entry 3 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,369,568 F3 · price: This constitutes the weighted average sale price. The prices range from $131.34 to $134.96. The Reporting Persons will provide upon request by the SEC Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 22:50 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
SaleCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-21-003110 · ownership.xml · nonDerivative · entry 2 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,423,422 F1 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 22:50 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
SaleCommon Stock | 20,669 | $130.34 | $2,693,997.46 |
DisclosureSEC source: 0000919574-21-003110 · ownership.xml · nonDerivative · entry 1 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,423,422 F2 · price: This constitutes the weighted average sale price. The prices range from $129.99 to $131.37. The Reporting Persons will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:16 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
GiftCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-21-002764 · ownership.xml · nonDerivative · entry 2 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 9,444,091 F1 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:16 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-21-002764 · ownership.xml · nonDerivative · entry 1 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,444,091 F2 · kind: On April 1, 2021, Broadwood Partners, acting at the direction a partner and as such partner's agent, transferred 100,000 shares of STAAR Surgical Company's common stock (the "Shares") to a charitable organization. No Shares were sold by Broadwood Partners. F2 · price: On April 1, 2021, Broadwood Partners, acting at the direction a partner and as such partner's agent, transferred 100,000 shares of STAAR Surgical Company's common stock (the "Shares") to a charitable organization. No Shares were sold by Broadwood Partners. F1 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| March 22, 2021 Filed Mar 22, 2021 23:01 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
SaleCommon Stock | 1,103 | $96.37 | $106,296.11 |
DisclosureSEC source: 0001209191-21-022444 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,691 Read SEC document |
| March 22, 2021 Filed Mar 22, 2021 23:00 UTC |
Gesten Samuel JChief Legal Officer
|
SaleCommon Stock | 1,032 | $96.37 | $99,453.84 |
DisclosureSEC source: 0001209191-21-022442 · doc4.xml · nonDerivative · entry 1 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,583 Read SEC document |
| March 22, 2021 Filed Mar 22, 2021 22:59 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
SaleCommon Stock | 922 | $96.37 | $88,853.14 |
DisclosureSEC source: 0001209191-21-022439 · doc4.xml · nonDerivative · entry 1 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,630 Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:45 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock Options · Derivative | 2,664 | $0.00 Strike: $15.25 | $0.00 |
DisclosureSEC source: 0001209191-21-021377 · doc4.xml · derivative · entry 3 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,671 Underlying: Common Stock · 2,664 shares Expires 2027-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:45 UTC |
Barnes Scott DChief Medical Officer
|
Disposition to issuerCommon Stock | 2,664 | $95.00 | $253,080.00 |
DisclosureSEC source: 0001209191-21-021377 · doc4.xml · nonDerivative · entry 2 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,390 Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:45 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock | 2,664 | $15.25 | $40,626.00 |
DisclosureSEC source: 0001209191-21-021377 · doc4.xml · nonDerivative · entry 1 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.